BCM Technologies (BCMT)
North America, Texas, United States, Houston
Description
BCM Technologies’ investment strategy revolves around the concept that maximum returns from early stage life science investing will result
Investor Profile
BCM Technologies (BCMT) has made 3 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (67%)
- Post Ipo Equity (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Developer Platform
- Bioinformatics
- Pharmaceutical
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
